1. Home
  2. HALO vs VFS Comparison

HALO vs VFS Comparison

Compare HALO & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • VFS
  • Stock Information
  • Founded
  • HALO 1998
  • VFS 2017
  • Country
  • HALO United States
  • VFS Vietnam
  • Employees
  • HALO N/A
  • VFS N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • VFS Blank Checks
  • Sector
  • HALO Health Care
  • VFS Finance
  • Exchange
  • HALO Nasdaq
  • VFS Nasdaq
  • Market Cap
  • HALO 7.6B
  • VFS 8.0B
  • IPO Year
  • HALO N/A
  • VFS N/A
  • Fundamental
  • Price
  • HALO $75.85
  • VFS $3.19
  • Analyst Decision
  • HALO Buy
  • VFS Buy
  • Analyst Count
  • HALO 8
  • VFS 3
  • Target Price
  • HALO $70.25
  • VFS $5.75
  • AVG Volume (30 Days)
  • HALO 1.9M
  • VFS 527.0K
  • Earning Date
  • HALO 10-30-2025
  • VFS 09-04-2025
  • Dividend Yield
  • HALO N/A
  • VFS N/A
  • EPS Growth
  • HALO 68.93
  • VFS N/A
  • EPS
  • HALO 4.37
  • VFS N/A
  • Revenue
  • HALO $1,178,672,000.00
  • VFS $2,363,353,531.00
  • Revenue This Year
  • HALO $32.57
  • VFS N/A
  • Revenue Next Year
  • HALO $23.25
  • VFS $39.97
  • P/E Ratio
  • HALO $17.35
  • VFS N/A
  • Revenue Growth
  • HALO 34.97
  • VFS 86.03
  • 52 Week Low
  • HALO $42.01
  • VFS $2.56
  • 52 Week High
  • HALO $77.60
  • VFS $5.38
  • Technical
  • Relative Strength Index (RSI)
  • HALO 53.16
  • VFS 35.43
  • Support Level
  • HALO N/A
  • VFS $3.35
  • Resistance Level
  • HALO $77.60
  • VFS $3.30
  • Average True Range (ATR)
  • HALO 1.53
  • VFS 0.08
  • MACD
  • HALO -3.05
  • VFS -0.02
  • Stochastic Oscillator
  • HALO 97.74
  • VFS 3.23

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

Share on Social Networks: